Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine
Multiple bloodglucose-lowering agents have been linked to cardiovascular events. Preliminary studies showed improvement in left ventricular (LV) function during glucagon-like peptide-1 receptor agonist adminis...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Weena J. Y. Chen, Michaela Diamant, Karin de Boer, Hendrik J. Harms, Lourens F. H. J. Robbers, Albert C. van Rossum, Mark H. H. Kramer, Adriaan A. Lammertsma and Paul Knaapen Source Type: research
More News: Byetta | Cardiology | Cardiomyopathy | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Insulin | Lantus | Perfusion | Study